EUVIMEDTutustu EUVIMEDiin
Crossref

Beyond Thiol-Enzyme Inhibition: Sterically Bulky NHC-Au(I) Complexes are Catalytically Active Anticancer Agents with Reprogrammed Immunomodulatory Function

Zhi Zhong, Haitao Liu, Qiong Wu, Bei Cao, Yujiao Peng, Moyi Liu, Liang-Mei Yang, Yue Lin, Ke-Bin Huang iD, Xiaolin Xiong, Jinsai Shang iD, Taotao Zou iD

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.5c19777 ↗

At a glance

Journal article in Journal of the American Chemical Society, 2026. Written by Zhi Zhong and 11 co-authors. Institution: State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, and School of …. Major MEDLINE topics: Antineoplastic Agents, Methane, Gold, Thioredoxin Reductase 1. Cited 4 times so far (Crossref); 132 references. Funded by: Science and Technology Planning Project of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Municipal Science and Technology Program key projects.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Metallodrug-induced immunogenicity offers significant potential for improving the efficacy of cancer immunotherapy with metals such as gold serving as a notable example. However, heavy metals may concurrently disrupt immune cell function, and a few of them can augment immunogenicity without compromising immunological integrity. Here, we report sterically bulky Au(I) complexes as catalytically active anticancer agents with the capability to reprogram immunomodulatory function. Our initial studies identified complex IPr-Au-Cl, characterized by bulky substituents, which catalytically activated an alkyne probe in the presence of GSH and triggered hydride transfer from NADH to NAD+. Subsequent structural optimization led to the development of Au-8, which showed an increased catalytic activity and improved cytotoxicity against cancer cells. Although Au-8 induced elevated ROS levels and immunogenic CRT exposure in cancer cells akin to auranofin, it triggered unique proteomic responses, notably showing minimal inhibition of thioredoxin reductase 1 (TrxR1), a crucial protein for maintaining immune cell function. Auranofin's inhibition of TrxR1 resulted in immunosuppression at one-seventh of its cytotoxic IC50 against cancer cells. In contrast, Au-8 not only maintained but also enhanced immune function in vitro, ex vivo, and in vivo, including activated immunogenic phagocytosis and cytotoxic effects in human peripheral blood mononuclear cells isolated from healthy donors. This study, therefore, presents a novel design for gold compounds that leverages steric hindrance to achieve catalytic anticancer activity without affecting TrxR1, opening avenues for future gold-based therapeutics with desirable immunomodulatory effects.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsMethaneGoldThioredoxin Reductase 1Enzyme InhibitorsOrganogold CompoundsSulfhydryl CompoundsHumansCatalysisCell Line, TumorDrug Screening Assays, AntitumorAnimalsMolecular Structure

Substances

Antineoplastic AgentsMethaneGoldcarbeneThioredoxin Reductase 1Enzyme InhibitorsOrganogold CompoundsSulfhydryl Compounds

Authors and institutions

  • State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, and School of Pharmaceutical Sciences, Sun Yat-Sen University Guangzhou 510006, Chin…
  • School of Basic Medical Sciences, State Key Laboratory of Respiratory Disease, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou 511436, China.
  • College of Education Sciences, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511453, China.
  • Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China.
  • Senior Department of Nephrology, Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, Beijing 100853, China.

ORCID profiles: Ke-Bin Huang, Jinsai Shang, Taotao Zou

Funding

  • Science and Technology Planning Project of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangzhou Municipal Science and Technology Program key projects
  • National Natural Science Foundation of China
  • Guangdong Provincial Key Lab of Chiral Molecule and Drug Discovery
  • Major Program of Guangzhou National Laboratory

Cite

APA

Zhong, Z., Liu, H., Wu, Q., Cao, B., Peng, Y., Liu, M., Yang, L. M., Lin, Y., Huang, K. B., Xiong, X., Shang, J., & Zou, T. (2026). Beyond Thiol-Enzyme Inhibition: Sterically Bulky NHC-Au(I) Complexes are Catalytically Active Anticancer Agents with Reprogrammed Immunomodulatory Function. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c19777

Vancouver

Zhong Z, Liu H, Wu Q, Cao B, Peng Y, Liu M, et al. Beyond Thiol-Enzyme Inhibition: Sterically Bulky NHC-Au(I) Complexes are Catalytically Active Anticancer Agents with Reprogrammed Immunomodulatory Function. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.5c19777

BibTeX
@article{Zhong2026,
  author = {Zhong, Zhi and Liu, Haitao and Wu, Qiong and Cao, Bei and Peng, Yujiao and Liu, Moyi and Yang, Liang-Mei and Lin, Yue and Huang, Ke-Bin and Xiong, Xiaolin and Shang, Jinsai and Zou, Taotao},
  title = {Beyond Thiol-Enzyme Inhibition: Sterically Bulky NHC-Au(I) Complexes are Catalytically Active Anticancer Agents with Reprogrammed Immunomodulatory Function},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.5c19777}
}
Start for free →